Cigna Group’s drug benefit unit is offering a new way for health plans to cover expensive weight-loss drugs that it says ... patients would pay less than the cash price for Eli Lilly & Co ...

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

Getting access to popular weight loss drugs will be simpler and cheaper for some. Evernorth, the health services division of The Cigna Group, announced the benefit that will make popular weight ...

The Cigna Group (NYSE:CI)’s Evernorth division has announced a new deal with Novo Nordisk and Eli Lilly that will limit insured customers’ monthly out-of-pocket expenses for weight-loss drugs Zepbound ...

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

Cigna's pricing compares to the cash-pay market for weight-loss drugs, said Harold Carter, a senior vice president at Evernorth. Sign up here. The $200 co-pays would count toward a patient's ...

Cigna’s (NYSE:CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at $200 per month for patients using the weight-loss drugs - Wegovy from ...

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

Only half of health insurer Cigna's clients currently cover the popular GLP-1 weight loss drugs ... a deal with drug makers Ely Lilly and Novo Nordisk which it said will bring prices down for ...

"This solution is really focused towards clients that aren't covering it today, and what it allows us to do is one, to bring it on at a reduced price ... offering the weight loss drugs.